Zobel G, Kuttnig M, Grubbauer H M, Semmelrock H J, Thiel W
Department of Pediatrics, University of Graz, Austria.
Crit Care Med. 1991 Oct;19(10):1242-6. doi: 10.1097/00003246-199110000-00005.
To compare the effects of two different antibiotic regimes on the colonization and infection rates of critically ill pediatric patients.
A prospective randomized trial.
A pediatric ICU in a university hospital.
Fifty critically ill pediatric patients who required intensive care for at least 4 days were randomly allocated to either the selective parenteral and enteral antisepsis regimen (treatment group, n = 25) or the control group (n = 25).
The treatment group received oral nonabsorbable antimicrobial agents (polymyxin E, gentamicin, and amphotericin B) and parenteral cefotaxime, whereas the control group received either perioperative antibiotic prophylaxis or antibiotic therapy according to clinical or microbiological evidence of infection.
Both groups were comparable for age, body weight, sex, and severity of illness. Colonization with Gram-negative microorganisms and yeasts in the oropharynx, and digestive and respiratory tracts increased rapidly up to 52% in the control group, whereas there was no colonization with these microorganisms in the treatment group. The occurrence rates of acquired secondary infections in the control and treatment groups were 36% and 8%, respectively (p less than .025). There were no differences between groups in the duration of intensive care or mortality rate.
Selective oropharyngeal and gastrointestinal decontamination combined with systemic cefotaxime application allows for a significant reduction of the colonization rate with Gram-negative bacteria and yeasts in critically ill pediatric patients undergoing prolonged intensive care. In addition, it significantly reduces the Gram-negative infection rate of the respiratory system. However, this therapeutic approach does not alter ICU length of stay or mortality rate.
比较两种不同抗生素治疗方案对危重症儿科患者定植和感染率的影响。
一项前瞻性随机试验。
一所大学医院的儿科重症监护病房。
50例需要至少4天重症监护的危重症儿科患者被随机分为选择性肠外和肠内抗菌方案组(治疗组,n = 25)或对照组(n = 25)。
治疗组接受口服不吸收抗菌药物(多粘菌素E、庆大霉素和两性霉素B)和肠外头孢噻肟,而对照组根据感染的临床或微生物学证据接受围手术期抗生素预防或抗生素治疗。
两组在年龄、体重、性别和疾病严重程度方面具有可比性。对照组口咽、消化道和呼吸道革兰氏阴性微生物和酵母菌的定植迅速增加,高达52%,而治疗组未出现这些微生物的定植。对照组和治疗组获得性继发感染的发生率分别为36%和8%(p < 0.025)。两组在重症监护持续时间或死亡率方面无差异。
选择性口咽和胃肠道去污联合全身应用头孢噻肟可显著降低接受长期重症监护的危重症儿科患者革兰氏阴性菌和酵母菌的定植率。此外,它还显著降低了呼吸系统革兰氏阴性菌感染率。然而,这种治疗方法不会改变重症监护病房住院时间或死亡率。